biostudies-literatureUnknown2(1)Bosserman REIn a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.Antimicrobial stewardship & healthcare epidemiology : ASHEe93https://www.ebi.ac.uk/biostudies/studies/S-EPMC9726486biostudies-literatureAntibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.PMC9726486Cass CKwon JHFarnsworth CWStruttmann EO'Neil CAOlsen MABabcock HMBosserman REBallman CBudge PJWallace MAArter OFraser VJStewart HBurnham CDCDC Prevention EpicentersPeacock KPark DfalseAntibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection.In a prospective cohort of healthcare personnel (HCP), we measured severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) nucleocapsid IgG antibodies after SARS-CoV-2 infection. Among 79 HCP, 68 (86%) were seropositive 14-28 days after their positive PCR test, and 54 (77%) of 70 were seropositive at the 70-180-day follow-up. Many seropositive HCP (95%) experienced an antibody decline by the second visit.2022-01-01T00:00:00Z20222025-04-19T05:54:42.247Z2025-04-19T05:54:42.247ZS-EPMC97264863648336310.1017/ash.2022.231